RT Journal Article
SR Electronic
T1 Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e000829
DO 10.1136/jitc-2020-000829
VO 8
IS 1
A1 Zamarin, Dmitriy
A1 Walderich, Sven
A1 Holland, Aliya
A1 Zhou, Qin
A1 Iasonos, Alexia E
A1 Torrisi, Jean M
A1 Merghoub, Taha
A1 Chesebrough, Lewis F
A1 Mcdonnell, Autumn S
A1 Gallagher, Jacqueline M
A1 Li, Yanyun
A1 Hollmann, Travis J
A1 Grisham, Rachel N
A1 Erskine, Courtney L
A1 Block, Mathew S
A1 Knutson, Keith L
A1 O’Cearbhaill, Roisin E
A1 Aghajanian, Carol
A1 Konner, Jason A
YR 2020
UL http://jitc.bmj.com/content/8/1/e000829.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.